Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024

May 2025 in “ Pharmaceuticals ”

Zhonglei Wang, Xinjun Sun, Mingyu Sun, Chao Wang, Liyan Yang

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on mdpi.com →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences

11 citations , September 2024 in “Journal of the European Academy of Dermatology and Venereology”

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

63 citations , July 2024 in “Journal of the American Academy of Dermatology”